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ABSTRACT 
Avian viral problems have been consistently reported in commercial poultry of Pakistan causing heavy economic losses to the 
poultry farmers. Authentic idenfication and confirmation of the causative agent is always been question mark for the selection of 
vaccinal strain in this regard. Current study was therefore undertaken to optimize the virus neutralization test for the serological 
survey of vaccinated poultry particularly for avian influenza virus’s subtypes and Newcastle disease virus. Various physiochemical 
factors such as concentration of antigen and antibody, Incubation temperature and incubation period for in vitro and in-vivo 
reaction of antigen and antibody were optimized in chicken embryonated eggs. Serum samples were obtained from vaccinated 
breeder birds of five commercial poultry breeder companies and subjected for VNT using different concentration of three antigen 
and their respective homologous antibodies under optimized conditions. AIV H9 (EID50-1×109.0/ml) and NDV (EID50-1×108.2/ml) 
having biological titer of 10-7 /50ul  HA units were neutralize with 10-2/50ul HIU of antibody and incubated at 37C for 30 minutes 
was injected subsequently into 10 day old chicken embryo followed by incubation at 37C for 38 hours showed ≥90% neutralizing 
specificity. Furthermore, sera obtained from five AIV-H9, AIV-H5 and NDV exposed commercial poultry farms revealed that Big bird 
broiler, Big bird breeders and A&S chicks are 100% sensitive and specific whereas, Gateway chicks and Waqas poultry breeders 
showed 100% homology for AIV-H5 virus but do not confers similarity with prevailing AIV-H9 and NDV field strains. Therefore, high 
sensitivity, reproducibility and specificity VNT, it could be a tool for indirect detection of homology between vaccinal strain and wild 
virus antigen using known antisera. Particularly, for those organisms possess natural ability to mutate in the adverse climatic 
conditions. 
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INTRODUCTION 
Pakistan is an agriculture country and the major sub 
division of the agriculture has become the poultry 
production1 (Mushtaq, 1994). In Pakistan poultry sector is 
the feasible source of animal protein in term of egg and 
meat production. The enormous growth of the division is 
distinctively influenced by numerous viral, bacterial, 
protozoan and metabolic afflictions2 (Amare et al., 2012). 
Avian influenza (AI) is most infectious disease which is 
caused by several serotypes of influenza virus among all 
viral diseases. The first epidemic of avian influenza virus 
was in 1994. The subtype H5N1 of Avian influenza virus 
causes huge economical losses in Pakistan3, 4 (Muneer et al., 
1995, Nauta et al., 2005). The low pathogenic subtype of 
avian influenza is H9N2 which is still present in avian 
species. In Pakistan first outbreak of avian influenza virus 
subtype H9N2 was reported in 1999 which was also found 
in young and lying birds5, 6 (Naeem et al., 1999; Bano et al., 
2003). Newcastle disease (ND) is a lethal viral disorder 
first originated in England in 1926(Barbezange and Jestin, 
2005)7.   
Virus neutralization test (VNT) is one of the biological tests 
used for the semi quantitative detection of antigen and 
antibody. It has been also used in variety of 
epidemiological studies to carry out the seroprevalence. 
The development of VNT is described, evaluating the 
diagnostic specificity and sensitivity, repeatability and 
reproducibility8 (Loeffen et al., 2012). VNT is also known 
as micro neutralization assay which measures the 
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concentration of antibodies present in the serum to block 
the receptors of the virus to penetrate into the cell during 
into vitro trans infection. Although, neutralization is 
intuitively more appealing because it is more closely 
mirrors the disease process in vivo, it considered harder to 
standardize across laboratories9, 10 (Stephenson et al., 
2007; Wood et al., 2012). 
In influenza virus for the detection of specific neutralizing 
antibodies microneutralization test is used which is highly 
specific and sensitive assay in human and animal sera. 
Furthermore, it is also used for the detection of human 
antibodies to avian subtypes (WHO, 2013). Neutralizing 
antibodies play an important role in defense against 
influenza virus11, 12 (Burton et al., 2012, Gerhard, 2001). 
Neutralizing antibodies chiefly affect the heamagglutinin 
protein and glycoprotein. Glycoprotein is the main envelop 
of the influenza virus13 (Bertram et al., 2010). So, micro 
neutralization test is used as Gold standard for sub typing 
of influenza virus now days (Kwang et al., 2013). 
Research has shown that virus neutralization test is used 
with monoclonal antibodies to determine the antigenic 
difference between the strains of Newcastle disease virus. 
It is also used to evaluate the sequences of neutralizing 
epitopes14 (Panshin et al., 2002).  Two serotypes of the 
virus have been identified which are serotype 1 and 
serotype 2. Serotype 1 virus is very dangerous to chicken 
and also it is further classified into two types which are 
classic and variant. Serotype 2 virus is nonpathogenic to 
the chicken. To differentiate between the elicited 
antibodies by the two serotypes of serotype 1 virus the 
virus neutralization test is used (Ashraf et al., 2005). 
The application of virus neutralization assay is very simple 
and easy when a significant concentration of antibody is 
present; the antibody is identified by adding undiluted 
fluid such as blood serum in which suspected antibody is 
also present for the suspension and it also contains a 
known concentration of antigen. It is used to observe the 
geographic diffusion of its antigen and the titer of antibody 
in an anti-serum. The immunological factors of any disease 
are underlying to these principles15 (peter et al., 1947). 
MATERIALS AND METHOD 
Source of virus: 
Five ml of each characterized Avian influenza H5N1, H9N2 
(Tahir et al., 2016)17 and ND live viruses (Vaccinal strains) 
were officially obtained from Ottoman Pharma (Immuno 
division) licensed veterinary vaccine manufacturing 
company located at 10-km Raiwind road, Lahore Pakistan 
on the written request of director IMBB, The University of 
Lahore. 
Source of antibody: 
Two milliliter of monoclonal antisera against each strain of 
AIV-H5N1, AIV-H9N2 and ND virus was purchased from 
GD- diagnostic Holland. Furthermore, total of 25 blood 
samples were collected from 5 commercial breeders farms 
located in the periphery of Lahore, Pakistan and were also 
stored at -80C till further use. 
Source of embryos: 
Ten day old chicken embryonated eggs were purchased 
from big bird poultry breeders located at Raiwind road, 
Lahore. External surface of the eggs were disinfected with 
2% pyodine, ethanol solution and transferred to the 
incubator at 37C till inoculation of virus. 
 
Optimization of VNT: 
Many variables were optimized during the study for the 
best neutralization of homologous antigen and antibody 
under controlled condition. However each of the following 
parameters were tested for five times in every experiment: 
1. Concentration of antigen 
2. Concentration of antibody  
3. In vitro Incubation temperature 
4. In vitro incubation period 
5. In vivo Incubation Temperature 
6. In vivo incubation Period 
Final Protocol: 
Inoculation: 
Antigen and antisera suspension was centrifuged at 3600g 
for five minutes. 0.1ml of supernatant was inoculated 
through the air sac opening with one ml disposable syringe 
by inserting the needle (25G) into the allantoic sac of the 
egg. The opening of the each egg was sealed with sterilized 
molten wax and the eggs were incubated along with non-
inoculated control eggs at 37C for 48 hours till the 
cultivation of the virus. 
Harvesting of antigen: 
The eggs were chilled at -10°C for 30 minutes. The shell 
was cut above the air sac and carefully removed. The 
chorioallantoic membrane (CAM) and the amniotic 
membrane were turned with the help of sterile forceps, 
and the allantoic fluid was collected. 
Control groups: 
Five serum samples were obtained from non-exposed AIV 
and ND vaccinates. The samples were evaluated for 
relevant virus exposure through PCR and HI test using 
homologous antigens.  
Spot Haemagglutination: 
Sterile glass slide was labeled with respect to the marked 
eggs and test tubes containing allantoic harvest. Equal 
quantity (200ul) of each 25% washed chicken RBCs and 
harvested allantoic fluid were mixed on a clean glass slide 
allowed to react with each other for 2 minutes and results 
were recorded. 
Haemagglutination of allantoic fluid17: 
The HA test was performed using chicken erythrocytes and 
harvested allantoic fluid according to the method 
described by Allan et al., 1978. 
Specificity, sensitivity and repeatability: 
Each of the factor optimized in the study was run five times 
and data was evaluated through mean standard deviation 
(M±SD) to get p-value on the basis of Bonferroni analysis. 
Moreover, 25 virus free serum samples were tested in the 
final version of the assay. They were used in the test 
according to the cut off value in the assay to estimate the 
specificity, sensitivity and reproducibility.  
RESULTS 
Several parameters were optimized for virus 
neutralization test using different concentrations of 
antigen and antibody for AIV-H5, AIV-H9 and NDV in the 
study. It was recorded that AIV-H5 antigen best neutralize 
at concentration of 1×10-7 with antibody concentration of 
1×10-2. In Vitro optimum incubation temperature was 37°C 
for 60 minutes as compare to in-vivo chicken embryonated 
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eggs temperature 37°C for 38 hours. Similarly, AIV-H9 
antigen finest neutralization occurred at concentration of 
1×10-7 with antibody concentration of 1×10-2. In Vitro 
optimum incubation temperature was 37°C for 30 minutes 
as compare to in-vivo chicken embryonated eggs 
temperature that was 37°C for 38 hours. Whereas, NDV 
antigen and antibody greatest neutralization observed at 
antigen concentration of 1×10-7 with antibody titer of 
1×10-2. In Vitro optimum incubation temperature was 37°C 
for 30 minutes as compare to in-vivo chicken embryonated 
eggs temperature was 37°C for 38 hours (Fig, 1,2,3,4,5). 
Antigen and antibody concentration was considered as one 
of the critical variable in neutralization process and it was 
observed that increase in antigen or antibody count may 
adversely affect the sensitivity of the assay. At highest 
antigen 1×10-8 with lowest antibody level 1×10-0 did not 
show significant neutralization indicated by HA titer after 
incubation at optimized incubation temperature (37°C) 
and time period (38 hours). 
Serum samples collected from AIV and NDV confirmed 
infected birds showed higher anti-HI titers (64 HIU) from 
non-infected flocks. On the basis of these results the cut off 
value was set to 64 HAU. Serum samples from five poultry 
breeder companies were test through VNT using five 
mentioned optimized conditions for three different 
viruses. It was found that Big Bird Poultry breeder and big 
bird foods showed 12±4.38, 41±21.46 and 32±19.59 mean 
standard deviation (M+SD) status of allantoic fluid 
harvested post in vivo neutralization HA for H5, H9 and 
NDV respectively. Serum samples from A&S chicks showed 
32±19.59, 14±3.57 and 17±4.38 (M+SD) status of allantoic 
fluid harvested post in vivo neutralization HA for H5, H9 
and NDV respectively. Whereas, Gateway chicks showed 
17±4.38, 102±35.05, 256±156.76 (M+SD) status of 
allantoic fluid harvested post in-vivo neutralization HA for 
H5, H9 and NDV respectively. Similarly, Waqas poultry 
revelead 41±21.46, 819±280 and 716±280.43 (M+SD) 
status of allantoic fluid harvested post invivo 
neutralization HA for H5, H9 and NDV respectively as 
shown in Fig. 6.   
DISCUSSION 
Wide ranges of biochemical and serological tests have been 
used for the detection of animal and human disease 
causing pathogen. It is imperative to have authentic 
method to evaluate and confirm the organism. Various 
serological tests are being used for the confirmation of 
isolates and antibodies actively raised against vaccines.  
In current studies virus neutralization test was developed 
showing high specificity and sensitivity for avian influenza 
viruses subtype AIV-H5, AIV-H9 and Newcastle disease 
virus. The assay was reproduced and repeated for antisera 
collected from different vicinities of Lahore and displayed 
high level of homology to immunoglublins actively raised 
against vaccination in commercial poultry flocks. However, 
sera obtained from the flocks were hit by ND and AIV-H9 at 
different age did not show any significant resemblance to 
the antigen. VNT for embryonated egg adapted viruses is 
easy to perform and can be evaluated by spot 
heamagglutination using 25% washed chicken RBCs. 
Despite of excessive vaccination in commercial poultry 
viral problems has been reported with massive economical 
losses. In most of the cases researcher believed that the 
inefficiency of vaccines against their specific wild antigen is 
due to change in genotype often posed by pre disposing 
factors. Furthermore, influenza viruses are remained 
focused in research due its unique nature of nucleic acid 
which is prone to rapid mutation facilitated by the process 
of reassortment. Fusion protein (F) controlled by F gene of 
Newcastle disease virus is another unique phenomenon 
supporting the virus in attachment and penetration in to 
the cell. Mutation in F gene results in alteration of 
expressed proteins which cannot neutralize native antigen. 
Therefore, in order to rule out the cause of vaccine failure, 
VNT is the most effective technique could be used to 
investigate the homology between vicinal strain and wild 
type antigen. It is imperative to have authentic technique 
for evaluation of immunogenicity. Neutralizing antibody 
response to the viruses is serotype specific and VNT is 
considered as gold standard to detect avian influenza and 
Newcastle disease virus neutralizing antibodies. 
In current study it was observed factors such as amount of 
antigen and antibody, temperature and incubation time 
affected the neutralization reaction in-vitro and in-vivo in 
chicken embryonated eggs. Each of the factors has critical 
significance in antigen antibody neutralization reaction. 
The optimum neutralization reaction set for AIV-H7, AIV-
H9 and NDV were antigen (512 HAU) 1×10-7 versus 1×10-2 
of antibody (512 HIU), 37°C for 38 hours of incubation. 
However, AIV-H9 was significantly has better 
neutralization results when incubated at 37C for 38 hours. 
Olitsky and Harford 1938, Morgan, 1945 are in partial 
agreement with data obtained in current studies that the 
degree of neutralization in extra neural test is maximal and 
was not influenced by incubation23. 
 It is evident that temperature has significant role in the 
neutralization of specific antigen and antibody under 
specified physiochemical conditions. Whereas, In vitro 
antigen antibody neutralization results revealed that AIV-
H9 and NDV are more susceptible for neutralization 
reaction at 37C if incubated for 30 minutes in contrast to 
AIV-H5 which showed better neutralization at 37C for 60 
minutes. So, Li et al., 1994 collaborates that immuno 
precipitation and neutralization reaction are thermal 
dependent and require co incubation of virus and antisera 
particularly at 37C which can act as catalyst for antisera 
against peptides corresponding to normal internal potions 
of VP1 that have the ability to precipitate virus. 
Andrewes and Elford, 1933 described that antigen and 
antibody neutralization reaction, antibody neutralize the 
relative proportion of specific antigen on the basis of 
percentage law. Dilution factor of antigen such as AIV-H5, 
AIV-H9 and NDV showed significant neutralization at 10-6, 
10-4 and 10-1 respectively21. Diluted Antiserum reacts at 
its best at the level of 10-2 against 10-7 dilution of AIV-H5, 
AIV-H9 and NDV antigen titer. However, Klein et al., 1999 
partial agreed that if concentration of human 
cytomegalovirus was increased up to 100 fold does not 
affect the titer of neutralizing sera. Further explanation 
was made on the basis of observation that assay performed 
under ordinary conditions relative occupancy of viral 
epitopes is masked by antibody titer and its functional 
affinity for antigenic determent20 (Klasse, 1996). 
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Figure 1: Effect of antigen and antibody dilution factor on virus neutralization test 
 
Figure 2: In vitro effect of temperature on the antigen 
and antibody neutralization reaction 
 
Figure 3: In vitro effect of incubation period on the 
antigen and antibody neutralization reaction 
 
Figure 4: In vivo effect of temperature on the 
inoculated eggs for virus neutralization test 
 
Figure 5: In vivo effect of incubation period on the 
inoculated eggs for virus neutralization test
 
 
Figure 6: Serum neutralization of samples collected from birds naturally exposed with AI and NDV 
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Figure 7: Ag, Ab dilution and mixing 
 
Figure 8: Steps involved in virus inoculation into embryonated chicken eggs 
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Figure 9: Harvesting of antigen                                 Figure 10: Spot agglutination of allantoic harvest 
 
Figure 11: Haemagglutination of allantoic harvest 
 
CONCLUSION 
In antigen antibody reactions, both of the participants shall 
be highly specific and require certain optimal 
physiochemical factors for their neutralization. It is evident 
based on the results of current study that for in vitro 
neutralization reaction two phases must be considered to 
get reliable results. Firstly in vitro antigen and antibody 
reaction is predominantly influenced by biological titer of 
virus and antibody concentration, temperature and 
incubation period followed by in vivo elusion of antigen 
and antibody association is greatly affected by temperature 
and incubation period. The optimized technique of virus 
neutralization could be used for mass scale screening of 
Avian influenza and Newcastle disease virus infected birds.  
Moreover, the test can be best applied for the detection of 
different serotypes prevalent in the environment has been 
considered as the cause of vaccine failure. Confirmation of 
prevalent wild strain makes scientists able to design 
strategy of vaccination for effective immune-prophylaxis 
measures against natural outbreaks of new castle disease 
and avian influenza virus. 
 
Anwar et al                                                                                                      Journal of Drug Delivery & Therapeutics. 2018; 8(6):142-148 
ISSN: 2250-1177                                                                                 [148]                                                                                  CODEN (USA): JDDTAO 
ACKNOWLEDGEMENT 
The authors of the paper are highly grateful to Mr. Usman 
Farooq Khalid the director of Ottoman Pharma (Immuno 
Division) for providing financial support, isolate of Avian 
influenza virus, Newcastle disease virus and laboratory 
facility to execute the research in the best interest of the 
poultry industry. 
  
REFERENCES 
1. Mushtaq AM. Poultry production. In: Animal husbandry. 
National Book Foundation, Islamabad. 1994; pp: 292-334.  
2. Amare A, Worku N, Negussie H. Coccidiosis Prevailing in 
Parent Stocks: A Comparative Study between Growers and 
Adult Layers in Kombolcha Poultry Breeding and 
Multiplication Center, Ethiopia. Global Veterinaria. 2012; 
8(3):285-291. 
3. Muneer MA, Muhammad K, Tahir Y. Pathways to control Avian 
Influenza in Pakistan. In: Agro Veterinary News. 1995; pp: 2-3. 
4. Nauta JJ, Eliminating bias in the estimation of the geometric 
mean of HA titers. Biology. 2005; 35:149-151. 
5. Naeem K, Ullah A, Manvell RJ, Alexander DJ, Avian influenza A 
subtype H9N2 in poultry in Pakistan. Veterinary Record. 1999; 
145(19):560.   
6. Bano S, Naeem K, Malik SA. Evaluation of pathogenic potential 
of avian influenza virus serotype H9N2 in chickens. Avian 
Distribution. 2003; 47(3):817-822. 
7. Barbezange C, Jestin V. Quasi-species nature of an unusual 
Avian Paramyxovirus type-1 isolated from pigeons. Virus 
Genes. 2005; 53:224-40. 
8. Laoeffen W, Qwak S, Boer-luijtez ED, Hulst M, Poel WVD, 
Bouwstra R, Mass R. Development of a virus neutralization 
test to detect antibodies against Schmallenberg virus and 
serological results in suspect and infected herds. Acta 
Veterinaria Scandinavica. 2012; 2012:44-54. 
9. Stephenson I, Das RG, Wood JM, Katz JM. Comparison of 
neutralizing antibody assays for detection of antibody to 
influenza A/H3N2 viruses: an international collaborative 
study. Vaccine. 2007; 25:4056-4063. 
10. Wood JM, Major D, Health A, Newman RW, Stepheson I, Clark 
T, Katz JM, Zambon MC. Reproducibility of serology assays for 
pandemic influenza H1N1: collaborative study to evaluate a 
candidate WHO international standard. Vaccine. 2012; 30:210-
217. 
11. Burton DR, Poignard P, Stainfield RL, Wilson IA. Broadly 
neutralizing antibodies present new prospects to counter 
highly antigenically diverse virses. Science. 2012; 337:183-
186. 
12. Gerhard W. The role of antibody response in influenza virus 
infection. Cur tor microbial Immunology. 2001; 260:171-190. 
13. Bertram S, Glowacka I, Kuhl A, Pholmann S. Novel insights into 
proteolytic cleavage of influenza virus heamagglutinin. Rev. 
Medical Virology. 2010; 20:298-310. 
14. Panshin A, Shihmanter E, Weisman Y, Orvell C, Lipkind M. 
Antigenic heterogeneity among the field isolates of Newcastle 
disease virus (NDV) in relation to the vaccine strain 1. Studies 
on viruses isolated from wild birds in Israel Comparative 
Immunology Microbiology. 2002; 25:95-108. 
15. Peter K, Olitsky MD, Casals MD. Neutralization tests for 
diagnosis of Human virus encephalitides. Journal of the 
American Medical Association. 1947; 134(15):1224-1228. 
16. Tahir MS, Mehmood D, Sultan U, Saeed MH, Khan AR, Ansari F, 
Salman MM, Majeed KA. A modified strategy of multiplex RT-
PCR for simultaneous detection of H5, H7 and H9 subtype of 
avian influenza virus based on common forward oligo. Journal 
of Applied Poultry Research. 2016; 25:322-327.  
17. Allan WH, Lancaster JE, Toth B. Newcastle disease vaccines, 
their production and use. FAO animal production and health 
series. 1978; 57-62. 
18. Qihan LI, Alicia GY, Young ML, James H, Marie C. Poliovirus 
neutralization by antibodies to internal epitopes of VP4 and 
VP1 results from reversible exposure of these sequences at 
physiological temperature. Journal of Virology. 1994; 64:3965-
3970. 
19. Klein M, Schoppel K, Amvrossiadis N, Mach M. Strain specific 
neutralization of human cytomegalovirus isolates by human 
sera. Journal of Virology. 1999; 73:878-886. 
20. Klasse PJ, Moore JP. Quantitative model of antibody and 
soluble CD4-mediated neutralization of primary isolates and 
T-cell line adapted strain of human immunodeficiency virus 
type 1. Journal of Virology. 1996; 70:3668-3677. 
21. Andrewes CH, Elford WJ. Observation on anti-phage sera. I. 
The percentage law. British Journal of Experimental Pathology. 
1993; 14:367-376. 
22. Hitchner SB. A virus neutralization screening test: Its 
limitations in classifying field isolates of infectious bronchitis 
virus. Avian Pathology. 1973; 2(2):103-109. 
23. Olitsky PK, Harford CG. Intraperitoneal and intracerebral 
routes in serum protection tests with virus of equine 
encephalomyelitis: Comparison of two routes in protection 
tests. The Journal of Experimental Medicine. 1938; 68:173-
189. 
24. Morgan IM. Quantitative study of the neutralization of western 
equine encephalomyelitis virus by its antiserum and the effect 
of complement. Journal of Immunology. 1945; 50:359-371.
 
 
 
